Copyright Reports & Markets. All rights reserved.

Global Celiac Disease Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Celiac Disease Drug Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Celiac Disease Drug Market Size Growth Rate by Product
      • 1.4.2 Distension
      • 1.4.3 Diarrhea
      • 1.4.4 Anorexia
      • 1.4.5 Others
    • 1.5 Market by End User
      • 1.5.1 Global Celiac Disease Drug Market Size Growth Rate by End User
      • 1.5.2 First line of treatment
      • 1.5.3 Second line of treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Celiac Disease Drug Market Size
      • 2.1.1 Global Celiac Disease Drug Revenue 2014-2025
      • 2.1.2 Global Celiac Disease Drug Sales 2014-2025
    • 2.2 Celiac Disease Drug Growth Rate by Regions
      • 2.2.1 Global Celiac Disease Drug Sales by Regions
      • 2.2.2 Global Celiac Disease Drug Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Celiac Disease Drug Sales by Manufacturers
      • 3.1.1 Celiac Disease Drug Sales by Manufacturers
      • 3.1.2 Celiac Disease Drug Sales Market Share by Manufacturers
      • 3.1.3 Global Celiac Disease Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Celiac Disease Drug Revenue by Manufacturers
      • 3.2.1 Celiac Disease Drug Revenue by Manufacturers (2014-2019)
      • 3.2.2 Celiac Disease Drug Revenue Share by Manufacturers (2014-2019)
    • 3.3 Celiac Disease Drug Price by Manufacturers
    • 3.4 Celiac Disease Drug Manufacturing Base Distribution, Product Types
      • 3.4.1 Celiac Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Celiac Disease Drug Product Type
      • 3.4.3 Date of International Manufacturers Enter into Celiac Disease Drug Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Celiac Disease Drug Sales by Product
    • 4.2 Global Celiac Disease Drug Revenue by Product
    • 4.3 Celiac Disease Drug Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Celiac Disease Drug Breakdown Data by End User

    6 North America

    • 6.1 North America Celiac Disease Drug by Countries
      • 6.1.1 North America Celiac Disease Drug Sales by Countries
      • 6.1.2 North America Celiac Disease Drug Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Celiac Disease Drug by Product
    • 6.3 North America Celiac Disease Drug by End User

    7 Europe

    • 7.1 Europe Celiac Disease Drug by Countries
      • 7.1.1 Europe Celiac Disease Drug Sales by Countries
      • 7.1.2 Europe Celiac Disease Drug Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Celiac Disease Drug by Product
    • 7.3 Europe Celiac Disease Drug by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Celiac Disease Drug by Countries
      • 8.1.1 Asia Pacific Celiac Disease Drug Sales by Countries
      • 8.1.2 Asia Pacific Celiac Disease Drug Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Celiac Disease Drug by Product
    • 8.3 Asia Pacific Celiac Disease Drug by End User

    9 Central & South America

    • 9.1 Central & South America Celiac Disease Drug by Countries
      • 9.1.1 Central & South America Celiac Disease Drug Sales by Countries
      • 9.1.2 Central & South America Celiac Disease Drug Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Celiac Disease Drug by Product
    • 9.3 Central & South America Celiac Disease Drug by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Celiac Disease Drug by Countries
      • 10.1.1 Middle East and Africa Celiac Disease Drug Sales by Countries
      • 10.1.2 Middle East and Africa Celiac Disease Drug Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Celiac Disease Drug by Product
    • 10.3 Middle East and Africa Celiac Disease Drug by End User

    11 Company Profiles

    • 11.1 F. Hoffmann-La Roche
      • 11.1.1 F. Hoffmann-La Roche Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 F. Hoffmann-La Roche Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 F. Hoffmann-La Roche Celiac Disease Drug Products Offered
      • 11.1.5 F. Hoffmann-La Roche Recent Development
    • 11.2 Johnson & Johnson
      • 11.2.1 Johnson & Johnson Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Johnson & Johnson Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Johnson & Johnson Celiac Disease Drug Products Offered
      • 11.2.5 Johnson & Johnson Recent Development
    • 11.3 Merck
      • 11.3.1 Merck Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Merck Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Merck Celiac Disease Drug Products Offered
      • 11.3.5 Merck Recent Development
    • 11.4 Pfizer
      • 11.4.1 Pfizer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Pfizer Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Pfizer Celiac Disease Drug Products Offered
      • 11.4.5 Pfizer Recent Development
    • 11.5 ADMA Biologics
      • 11.5.1 ADMA Biologics Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 ADMA Biologics Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 ADMA Biologics Celiac Disease Drug Products Offered
      • 11.5.5 ADMA Biologics Recent Development
    • 11.6 Amgen
      • 11.6.1 Amgen Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Amgen Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Amgen Celiac Disease Drug Products Offered
      • 11.6.5 Amgen Recent Development
    • 11.7 Anthera Pharmaceuticals
      • 11.7.1 Anthera Pharmaceuticals Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Anthera Pharmaceuticals Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Anthera Pharmaceuticals Celiac Disease Drug Products Offered
      • 11.7.5 Anthera Pharmaceuticals Recent Development
    • 11.8 Bayer
      • 11.8.1 Bayer Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Bayer Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Bayer Celiac Disease Drug Products Offered
      • 11.8.5 Bayer Recent Development
    • 11.9 Biogen
      • 11.9.1 Biogen Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Biogen Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Biogen Celiac Disease Drug Products Offered
      • 11.9.5 Biogen Recent Development
    • 11.10 BioLineRx
      • 11.10.1 BioLineRx Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 BioLineRx Celiac Disease Drug Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 BioLineRx Celiac Disease Drug Products Offered
      • 11.10.5 BioLineRx Recent Development
    • 11.11 Biotest
    • 11.12 Bristol-Myers Squibb
    • 11.13 Celgene
    • 11.14 Takeda Pharmaceutical
    • 11.15 Novartis
    • 11.16 LFB Group
    • 11.17 Kedrion Biopharma

    12 Future Forecast

    • 12.1 Celiac Disease Drug Market Forecast by Regions
      • 12.1.1 Global Celiac Disease Drug Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Celiac Disease Drug Revenue Forecast by Regions 2019-2025
    • 12.2 Celiac Disease Drug Market Forecast by Product
      • 12.2.1 Global Celiac Disease Drug Sales Forecast by Product 2019-2025
      • 12.2.2 Global Celiac Disease Drug Revenue Forecast by Product 2019-2025
    • 12.3 Celiac Disease Drug Market Forecast by End User
    • 12.4 North America Celiac Disease Drug Forecast
    • 12.5 Europe Celiac Disease Drug Forecast
    • 12.6 Asia Pacific Celiac Disease Drug Forecast
    • 12.7 Central & South America Celiac Disease Drug Forecast
    • 12.8 Middle East and Africa Celiac Disease Drug Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Celiac Disease Drug Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Celiac Disease Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Celiac Disease Drug market based on company, product type, end user and key regions.

      This report studies the global market size of Celiac Disease Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Celiac Disease Drug in these regions.
      This research report categorizes the global Celiac Disease Drug market by top players/brands, region, type and end user. This report also studies the global Celiac Disease Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      F. Hoffmann-La Roche
      Johnson & Johnson
      Merck
      Pfizer
      ADMA Biologics
      Amgen
      Anthera Pharmaceuticals
      Bayer
      Biogen
      BioLineRx
      Biotest
      Bristol-Myers Squibb
      Celgene
      Takeda Pharmaceutical
      Novartis
      LFB Group
      Kedrion Biopharma

      Market size by Product
      Distension
      Diarrhea
      Anorexia
      Others
      Market size by End User
      First line of treatment
      Second line of treatment

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Celiac Disease Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Celiac Disease Drug market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Celiac Disease Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Celiac Disease Drug submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Celiac Disease Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Celiac Disease Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now